73 related articles for article (PubMed ID: 30965187)
21. The psychosexual impact of human papillomavirus cervical infections.
Reed BD; Ruffin MT; Gorenflo DW; Zazove P
J Fam Pract; 1999 Feb; 48(2):110-6. PubMed ID: 10037541
[TBL] [Abstract][Full Text] [Related]
22. [Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region].
Hadzić B; Djurdjević S; Hadzić M; Jerant-Patić V
Med Pregl; 1998; 51(5-6):265-70. PubMed ID: 9720356
[TBL] [Abstract][Full Text] [Related]
23. Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1.
Ideström M; Milsom I; Andersson-Ellström A
Acta Obstet Gynecol Scand; 2003 Aug; 82(8):756-61. PubMed ID: 12848648
[TBL] [Abstract][Full Text] [Related]
24. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
[TBL] [Abstract][Full Text] [Related]
25. Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.
Elfgren K; Elfström KM; Naucler P; Arnheim-Dahlström L; Dillner J
Am J Obstet Gynecol; 2017 Mar; 216(3):264.e1-264.e7. PubMed ID: 27825977
[TBL] [Abstract][Full Text] [Related]
26. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
Kumakech E; Andersson S; Wabinga H; Musubika C; Kirimunda S; Berggren V
BMC Womens Health; 2017 Jun; 17(1):40. PubMed ID: 28576143
[TBL] [Abstract][Full Text] [Related]
27. The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions.
Wang KL; Jeng CJ; Yang YC; Chen CA; Cheng WF; Chen TC; Mast TC; Wang YC; Hsieh CY
J Psychosom Obstet Gynaecol; 2010 Mar; 31(1):16-23. PubMed ID: 20121461
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
30. Relation of p53 tumor suppressor protein expression to human papillomavirus (HPV) DNA and to cellular atypia in male genital warts and in premalignant lesions.
Ranki A; Lassus J; Niemi KM
Acta Derm Venereol; 1995 May; 75(3):180-6. PubMed ID: 7653176
[TBL] [Abstract][Full Text] [Related]
31. Knowledge of cervical dysplasia and human papillomavirus among women seen in a colposcopy clinic.
Pruitt SL; Parker PA; Peterson SK; Le T; Follen M; Basen-Engquist K
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S236-44. PubMed ID: 16150483
[TBL] [Abstract][Full Text] [Related]
32. HPV primary cervical screening in England: Women's awareness and attitudes.
Patel H; Moss EL; Sherman SM
Psychooncology; 2018 Jun; 27(6):1559-1564. PubMed ID: 29521462
[TBL] [Abstract][Full Text] [Related]
33. High-risk types of human papillomavirus associated with the progression of cervical dysplasia to carcinoma.
Saito J; Fukuda T; Hoshiai H; Noda K
J Obstet Gynaecol Res; 1999 Aug; 25(4):281-6. PubMed ID: 10540533
[TBL] [Abstract][Full Text] [Related]
34. Impact of different educational interventions on psychosocial well-being of women with a positive high-risk human papillomavirus and normal cervical cytology: a randomised trial.
Ngu SF; Wei N; Kwan TTC; Chu MMY; Tse KY; Chan KKL; Ngan HYS
J Psychosom Obstet Gynaecol; 2018 Jun; 39(2):146-155. PubMed ID: 28391730
[TBL] [Abstract][Full Text] [Related]
35. The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population.
Burkett BJ; Peterson CM; Birch LM; Brennan C; Nuckols ML; Ward BE; Crum CP
J Clin Epidemiol; 1992 Nov; 45(11):1295-302. PubMed ID: 1331341
[TBL] [Abstract][Full Text] [Related]
36. [Motives for abandoning the healthcare process for precancerous lesions of the uterine cervix].
Hernández-Alemán FR; Ornelas-Bernal LA; Apresa-García T; Sánchez-Garduño S; Martínez-Rodríguez OA; Hernández-Hernández DM
Rev Invest Clin; 2006; 58(3):217-27. PubMed ID: 16958297
[TBL] [Abstract][Full Text] [Related]
37. Developing a measure of health-related quality of life for women with cervical dysplasia resulting from human papillomavirus infection.
Rao D; Gela N; Daley EM; Kattezham R; Rodriguez G; Cella D
Int J STD AIDS; 2010 Oct; 21(10):697-701. PubMed ID: 21139148
[TBL] [Abstract][Full Text] [Related]
38. The impact of HPV diagnosis on women's sexual and mental health: preliminary findings.
Ferenidou F; Salakos N; Vaidakis N; Paltoglou G; Bakalianou K; Papadimitriou G; Creatsas G
Clin Exp Obstet Gynecol; 2012; 39(1):79-82. PubMed ID: 22675962
[TBL] [Abstract][Full Text] [Related]
39. Does Social and Religious Background Matter? A Study of the Psychosocial Impact of Human Papillomavirus on Lebanese Women.
Atallah D; El Feghaly C; El Feghaly M; Arab W; Khaddage A; Akiki M; El Kassis N; Chakra RA; Chahine G; Moubarak M
J Low Genit Tract Dis; 2022 Jan; 26(1):8-12. PubMed ID: 34928248
[TBL] [Abstract][Full Text] [Related]
40. Quality of Life for Women with Human Papillomavirus-induced Lesions.
Pereira-Caldeira NMV; Góes FGB; Almeida-Cruz MCM; Caliari JS; Pereira-Ávila FMV; Gir E
Rev Bras Ginecol Obstet; 2020 Apr; 42(4):211-217. PubMed ID: 32330963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
